Eli Lilly Commits $3.5 Billion to Pennsylvania Plant, Boosting Domestic Production of Next-Gen Drugs
Pharmaceutical giant Eli Lilly announces a major investment in a new Lehigh Valley manufacturing site, set to create hundreds of jobs and bolster U.S. production capacity for its in-demand injectable therapies, including weight-loss drugs.